Novel single‐entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient‐reported comfort
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16461 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Jovian Wan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Asia Pacific Aesthetic Academy, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Masseter Muscle, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Botulinum neurotoxin (BoNT) injections are widely used for the treatment of masseter muscle hypertrophy in Southeast Asia. However, there remains a lack of consensus regarding the optimal injection technique. This study aimed to compare the efficacy and patient discomfort associated with single‐entry point injections versus multiple three‐point injections for masseter muscle hypertrophy treatment with BoNT. Materials and Methods Sixteen participants, comprising both male and female Korean adults aged 22–63, were enrolled in the study. On the left side of the face, single‐entry point injections were administered, followed by multidirectional injections, while on the right side, three‐point injections were given. Pain intensity during the procedure was assessed using visual analogue scale scores.
Result
Our results revealed that participants experienced lower levels of pain with single‐entry point injections compared to three‐point injections (average visual analogue scores of 3.31 and 5.19, respectively).
Conclusion
These findings highlight the potential benefits of single‐entry point injections in reducing patient discomfort during masseter muscle hypertrophy treatment with BoNT. We advocate for further research to validate these findings and encourage practitioners to consider single‐entry point injections as a viable option for enhancing treatment outcomes in their clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Asia Pacific Aesthetic Academy, Hong Kong, Hong Kong.
- Kimjongseo Plastic Surgery Clinic, Seoul, South Korea.
- Obliv Clinic, Incheon, South Korea.
- Made-Young Plastic Surgery Clinic, Seoul, South Korea.
- Department of Surgery, Epworth Hawthorn and Epworth Eastern Private Hospitals, Melbourne, Victoria, Australia.
- Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
ORCID-Profile: Jong-Seo Kim, Hee-Jin Kim, Kyu-Ho Yi
Zitieren
APA
Wan, J., Kim, J. S., Park, Y., Park, S. Y., Koppert, E., Kim, H. J., & Yi, K. H. (2024). Novel single‐entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient‐reported comfort. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16461
Vancouver
Wan J, Kim JS, Park Y, Park SY, Koppert E, Kim HJ, et al. Novel single‐entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient‐reported comfort. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16461
BibTeX
@article{Wan2024,
author = {Wan, Jovian and Kim, Jong-Seo and Park, Youngjin and Park, Soo Yeon and Koppert, Erik and Kim, Hee-Jin and Yi, Kyu-Ho},
title = {Novel single‐entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient‐reported comfort},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16461}
}
EUVIMED